Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 21.09.2026 1 Am J Cardiol 1 Arch Bronconeumol 1 Arch Med Res 1 BMC Cardiovasc Disord 1 BMC Pediatr 1 BMC Pulm Med 1 BMJ Case Rep 1 Br J Clin Pharmacol 1 Cancers (Basel) 1 Chin Med J (Engl) 1 Comput Biol Chem 1 Curr Med Chem 1 Exp Lung Res 1 Front Immunol 1 Front Med (Lausanne) 4 Int J Mol Sci 1 J Cardiovasc Imaging 2 J Clin Med 1 J Vis Exp 2 Khirurgiia (Mosk) 1 Lung 1 Nat Rev Cardiol 1 Open Respir Arch 1 Pediatr Cardiol 1 PLoS One 2 Pulm Circ 1 Redox Biol 1 Respir Investig 1 Respir Res Clin Pract 2 Rheumatology (Oxford) 1 Stud Health Technol Inform 1 Toxicol Appl Pharmacol 1 Trop Doct 1 Zhonghua Er Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. YOKOMORI H, Ikeda N, Tsukagoshi Y, Waga S, et al
   Exercise Stress Echocardiographic Assessment of Exercise-Induced Pulmonary Hypertension in Patients with Chronic Thromboembolic Pulmonary Hypertension after Balloon Pulmonary Angioplasty.
   Am J Cardiol. 2026 Sep 13:S0002-9149(26)00573.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

2. PERACAULA M, Aguilar D, Vea A, Rodriguez C, et al
   Endothelial Cell Transcriptomics Reveal Activation of Ribosomal-related Pathways in Chronic Thromboembolic Pulmonary Hypertension.
   Arch Bronconeumol. 2026 Sep 18:S0300-2896(26)00329.
   PubMed         Abstract available
   
   

   
   Arch Med Res

3. CHEN Z, Cai Z, Chen S, Xie L, et al
   DNA Methylation-Mediated Regulation of TAGLN2 Expression Promotes Pulmonary Arterial Hypertension.
   Arch Med Res. 2026;57:103434.
   PubMed         Abstract available
   
   

   
   BMC Cardiovasc Disord

4. CHEN Y, Wang C, Lin Q, Chen J, et al
   Association of ACE2 gene polymorphisms with risk of pulmonary arterial hypertension in neonates with congenital heart disease.
   BMC Cardiovasc Disord. 2026;26:814.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

5. YEOM GE, Shin SH, Kim HS, Kim EK, et al
   Factors associated with short-term response after systemic corticosteroid treatment in invasively ventilated preterm infants.
   BMC Pediatr. 2026 Jun 29. doi: 10.1186/s12887-026-07119.
   PubMed         Abstract available
   
   

   
   BMC Pulm Med

6. FUJII H, Isobe S, Tamura Y
   Hemodynamic improvement but worsening hypoxemia after balloon pulmonary angioplasty: severe eosinophilic asthma unmasked in CTEPH.
   BMC Pulm Med. 2026;26:409.
   PubMed         Abstract available
   
   

   
   BMJ Case Rep

7. ALSUFYANI RH, Imran S, Mccullagh B, Hassan T, et al
   Riociguat as inpatient rescue therapy for acute decompensation of inoperable chronic thromboembolic pulmonary hypertension.
   BMJ Case Rep. 2026;19:e271552.
   PubMed         Abstract available
   
   

   
   Br J Clin Pharmacol

8. WONGWIEN P, Pussadhamma B, Kanjanawart S, Areesinpitak T, et al
   CYP3A5 genetic variability influences sildenafil and metabolite in pulmonary hypertension.
   Br J Clin Pharmacol. 2026 Sep 18. doi: 10.1002/bcp.70826.
   PubMed         Abstract available
   
   

   
   Cancers (Basel)

9. FERRANTE M, Ali HJ, Hobbs G, Leiva O, et al
   The Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms.
   Cancers (Basel). 2026;18:2775.
   PubMed         Abstract available
   
   

   
   Chin Med J (Engl)

10. ZHANG R, Wu Y, Gong S, Jiang Q, et al
    Severe pulmonary hypertension due to chronic lung disease: Relevant hemodynamic criteria from a multicenter cohort study.
    Chin Med J (Engl). 2026 Sep 15. doi: 10.1097/CM9.0000000000004293.
    PubMed        
    
    

    
    Comput Biol Chem

11. POURDADASHI A, Eskandari P, Najafabadi ZG, Tajari A, et al
    Integrated transcriptomic and machine learning analysis identifies female-associated candidate biomarkers in Idiopathic pulmonary arterial hypertension.
    Comput Biol Chem. 2026;125:109276.
    PubMed         Abstract available
    
    

    
    Curr Med Chem

12. ZACHARIOUDAKI E, Trivyza MS, Papasotiriou M, Tsakas S, et al
    Endothelin: A Potential Universal Systemic Biomarker.
    Curr Med Chem. 2026;33:2909-2924.
    PubMed         Abstract available
    
    

    
    Exp Lung Res

13. XU Y, Pang X
    Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.
    Exp Lung Res. 2026;52:196-206.
    PubMed         Abstract available
    
    

    
    Front Immunol

14. HE Y, Zhu Y, Lv Q, Wu H, et al
    NF-kappaB signaling as a critical inflammatory node in pulmonary arterial hypertension: from vascular remodeling to right heart failure.
    Front Immunol. 2026;17:1921908.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

15. TAN X, Luo M, Ma R, Liu H, et al
    AI-based prediction of pulmonary hypertension in COPD patients with cor pulmonale using clinical and CT features.
    Front Med (Lausanne). 2026;13:1869175.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

16. SAWCZAK F, Kukfisz A, Soloch A, Kurkiewicz-Sawczak K, et al
    Natriuretic Peptides as Predictors for the Diagnosis of Pulmonary Hypertension Secondary to Left Heart Disease and for the Assessment of Its Severity.
    Int J Mol Sci. 2026;27:7776.
    PubMed         Abstract available
    
    
17. SINGH K, Ali M, G KK, Palmo T, et al
    Integrated Cytokine and Immune Cell Profiling Reveals a Distinct Immune Signature Associated with High-Altitude Pulmonary Edema.
    Int J Mol Sci. 2026;27:7787.
    PubMed         Abstract available
    
    
18. CHOJNACKA K, Sibrecht G, Gruca-Stryjak K, Szczapa T, et al
    Severe Suprasystemic Refractory Pulmonary Hypertension in a Neonate with Stuve-Wiedemann Syndrome Associated with Biallelic LIFR Variants: Molecular Insights and a Neonatal Case Report.
    Int J Mol Sci. 2026;27:7824.
    PubMed         Abstract available
    
    
19. FERRANTELLI S, Del Cuore A, Cassataro G, Dell'Ajra L, et al
    Artificial Intelligence and Multi-Omics Approaches in the Precision Management of Pulmonary Hypertension: From Early Diagnosis to Therapeutic Stratification.
    Int J Mol Sci. 2026;27:7763.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Imaging

20. CHANG SA
    Pulmonary hypertension in pregnancy: hemodynamic challenges, maternal risk, and multidisciplinary management.
    J Cardiovasc Imaging. 2026;34:33.
    PubMed         Abstract available
    
    

    
    J Clin Med

21. MCQUADE C, Davoudi D, Lajkosz K, Donahoe L, et al
    Differences in Chronic Pulmonary Embolism Burden in Chronic Thromboembolic Disease with and Without Pulmonary Hypertension.
    J Clin Med. 2026;15:6878.
    PubMed         Abstract available
    
    
22. LIU SC, Ku M, Mohnani P, Borse T, et al
    Group 3 Pulmonary Hypertension: Mechanistic Insights, Clinical Challenges, and Evolving Therapies.
    J Clin Med. 2026;15:6810.
    PubMed         Abstract available
    
    

    
    J Vis Exp

23. WU M, Zhang L, Wang X, Xu S, et al
    Routine-Data Nomogram for Estimating Pulmonary Hypertension Risk in Elderly Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    Khirurgiia (Mosk)

24. OSADCHII AM, Zugurov IK, Simakova MA, Moiseeva OM, et al
    [Early outcomes of controllable pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a single-centre experience at the Almazov National Medical Research Centre].
    Khirurgiia (Mosk). 2026;.
    PubMed         Abstract available
    
    
25. OSADCHII AM, Zugurov IK, Simakova MA, Belyaninova IV, et al
    [Floating right atrial mass in a patient with suspected chronic thromboembolic pulmonary hypertension].
    Khirurgiia (Mosk). 2026;.
    PubMed         Abstract available
    
    

    
    Lung

26. ALLAHAM L, King B, Ali F, Gupta I, et al
    GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps.
    Lung. 2026;204:68.
    PubMed         Abstract available
    
    

    
    Nat Rev Cardiol

27. FERNANDEZ-RUIZ I
    Pulmonary artery denervation shows promising results for heart failure-related pulmonary hypertension.
    Nat Rev Cardiol. 2026 Sep 15. doi: 10.1038/s41569-026-01350.
    PubMed        
    
    

    
    Open Respir Arch

28. ALMEIDA SOUTO M, Baez M, Perri M, Zelaya de Leon N, et al
    Can a Multidisciplinary Team Change the Course of Chronic Thromboembolic Pulmonary Hypertension? Changes in Time to Diagnosis After PERT Implementation.
    Open Respir Arch. 2026;8:100663.
    PubMed         Abstract available
    
    

    
    Pediatr Cardiol

29. AKIN A
    Sotatercept in Pediatric Pulmonary Hypertension: Promising Hemodynamic Findings, but Are We Extrapolating Too Far?
    Pediatr Cardiol. 2026 Sep 18. doi: 10.1007/s00246-026-04492.
    PubMed         Abstract available
    
    

    
    PLoS One

30. IMERBTHAM T, Sriwantana T, Ngamjanyaporn P, Sotananusak T, et al
    Endothelial and platelet dysfunction in systemic sclerosis with pulmonary hypertension.
    PLoS One. 2026;21:e0357987.
    PubMed         Abstract available
    
    

    
    Pulm Circ

31. WANG J, Zheng S, Yiminniyaze R, Zheng H, et al
    Association Between Serum Uric Acid and Pulmonary Hypertension in Takayasu Arteritis With Pulmonary Artery Involvement: A Cross-Sectional Study.
    Pulm Circ. 2026;16:e70393.
    PubMed         Abstract available
    
    
32. GIRALDO-SANDOVAL M, Guerrero-Pinedo FA, Herrera-Pena AM, Agrado-Torres JD, et al
    Clinical Outcomes of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Cohort Study From a Latin American Care Center.
    Pulm Circ. 2026;16:e70411.
    PubMed         Abstract available
    
    

    
    Redox Biol

33. WANG Y, Liang Q, Gao Y, Geng J, et al
    Malate-aspartate shuttle inactivation drives pulmonary hypertension through glucose carbon flux rewiring and alpha-ketoglutarate-dependent epigenetic remodeling.
    Redox Biol. 2026;97:104400.
    PubMed         Abstract available
    
    

    
    Respir Investig

34. TAKEDA K, Shigeta A, Yamamoto K, Naito A, et al
    Prevalence and predictors of pulmonary hypertension in patients with progressive pulmonary fibrosis: A retrospective study.
    Respir Investig. 2026;64:101512.
    PubMed         Abstract available
    
    

    
    Respir Res Clin Pract

35. AMADO VM, Pereira MC, Correa RA, Campos FAFT, et al
    Brazilian guidelines for the pharmacological treatment of pulmonary hypertension. Official document of the Brazilian Thoracic Society based on the Grading of Recommendations Assessment, Development, and Evaluation methodology.
    Respir Res Clin Pract. 2026;52:e20250528.
    PubMed         Abstract available
    
    

    
    Rheumatology (Oxford)

36. YEN TH, Isomura Y, Suzuki M, Huang WN, et al
    Baseline disease activity index and forced vital capacity predict clinically meaningful complications and mortality in systemic sclerosis.
    Rheumatology (Oxford). 2026;65:keag481.
    PubMed         Abstract available
    
    
37. FARINA N, Bellando Randone S, Jenssen-Bjorkekjaer H, Sanges S, et al
    Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study.
    Rheumatology (Oxford). 2026 Sep 18:keag516. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Stud Health Technol Inform

38. SAM J, Spreuer T, Berger M, Yogeswaran A, et al
    Benchmarking AI Vibe Coding for Clinical Statistical Analysis: A Structured Evaluation in Pulmonary Hypertension Research.
    Stud Health Technol Inform. 2026;340:234-241.
    PubMed         Abstract available
    
    

    
    Toxicol Appl Pharmacol

39. PRESTES JP, de Oliveira VR, Zimmer A, Drosdowski D, et al
    Cardioprotective effects of melatonin in vitro and in two in vivo models of heart disease: Isoproterenol-induced cardiac injury and pulmonary hypertension.
    Toxicol Appl Pharmacol. 2026 Sep 17:118038. doi: 10.1016/j.taap.2026.118038.
    PubMed         Abstract available
    
    

    
    Trop Doct

40. SHASHIKALA NV, Arun KM, Ashwini RC, Patil M, et al
    Pulmonary arterial hypertension in infancy: A case series.
    Trop Doct. 2026;56:720-722.
    PubMed         Abstract available
    
    

    
    Zhonghua Er Ke Za Zhi

41. HE RX, Yang HM, Liu JR, Tang XL, et al
    [Etiological and clinical classification of pulmonary hypertension in children].
    Zhonghua Er Ke Za Zhi. 2026;64:1168-1172.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum